Vir Biotechnology, Inc.
VIR
$6.12
-$0.17-2.70%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 51.06% | -54.44% | -111.99% | 43.71% | 29.03% |
| Total Depreciation and Amortization | -0.35% | -32.02% | -5.69% | 0.85% | -2.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 42.21% | -62.73% | 74.91% | -7.71% | 11.09% |
| Change in Net Operating Assets | -197.19% | 843.75% | 97.14% | -150.85% | -10.29% |
| Cash from Operations | 48.89% | -120.28% | 28.84% | -1.36% | 30.74% |
| Capital Expenditure | -2.16% | -253.75% | 64.42% | -21.95% | 58.67% |
| Sale of Property, Plant, and Equipment | 49,000.00% | -98.68% | -28.89% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 16.32% | -42.92% | 612.03% | 128.82% | -86.96% |
| Cash from Investing | 18.66% | -43.95% | 644.57% | 127.12% | -77.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 545.00% | 42.03% | 0.00% | -134.50% | 403.03% |
| Issuance of Common Stock | 1,660.56% | -97.64% | 1,262.44% | -87.49% | 415.16% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3,974.19% | -98.95% | 1,835.53% | -90.95% | 506.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 202.87% | -138.66% | 269.15% | 61.71% | 1.61% |